Pan-tumor genomic biomarkers for PD-1 checkpoint blockade–based immunotherapyRăzvan Cristescu, David R. Kaufman, Robin Mogg et al.|Science|2018Cited by 2.3k
A Cancer Cell Program Promotes T Cell Exclusion and Resistance to Checkpoint BlockadeLivnat Jerby‐Arnon, Charles H. Yoon, Genevieve M. Boland et al.|Cell|2018Cited by 1.5k
Advances in the development of personalized neoantigen-based therapeutic cancer vaccinesEryn Blass, Patrick A. Ott|Nature Reviews Clinical Oncology|2021Cited by 1k
Ipilimumab Therapy in Patients With Advanced Melanoma and Preexisting Autoimmune DisordersDouglas B. Johnson, Joseph I. Clark, Ryan J. Sullivan et al.|JAMA Oncology|2015Cited by 656
Personal neoantigen vaccines induce persistent memory T cell responses and epitope spreading in patients with melanomaZhuting Hu, Patrick A. Ott|Nature Medicine|2021Cited by 502